Patent Term Extended Under 35 U.S.C.   156

  An interim extension of the term of U.S. Patent No. 4,048,306 has been
granted under 35 U.S.C.    156(e)(2) for a period of one year from the
second extended expiration date, September 13, 1996, of the patent. The
patent was previously extended for one year under 35 U.S.C.
156(d)(5). See 1167 OG 14, October 4, 1994. The patent was thereafter
extended for an additional year under 35 U.S.C.    156(e)(2). See 1182
OG 581, January 30, 1996. An application for patent term extension was
filed by Eli Lilly and Company, on behalf of the patent owner Boehringer
Ingelheim GmbH, based on approval of the product "DYNABAC  " by the
Food and Drug Administration.


                  Patent Term Extended Under 35 U.S.C.   156

  An interim extension of the term of U.S. Patent No. 4,154,839 has been
granted under 35 U.S.C.    156(e)(2) for a period of one year from the
original expiration date, November 2, 1996, of the patent. An
application for patent term extension was filed by Bayer
Aktingesellschaft based on approval of the product "NISOCOR"
("Nisoldipine coat-core tablet") by the Food and Drug Administration.


                  Patent Term Extended Under 35 U.S.C.   156

  Certificates extending the terms of the following patents were issued
on September 23, 1996.

U.S. Patent No. 4,275,063; Granted June 23, 1981, to Andrew M.
Creighton; Original Expiration Date: June 23, 1998; Owner of Record:
British Technology Group Limited; Title: Pharmaceutical Compositions;
Classification: 514/252; Product Trade Name: ZINECARD tm; Term Extended:
Five Years.

U.S. Patent No. 4,307,100; Granted: December 22, 1981, to Nicole
Langlois et al.; Original Expiration Date: August 20, 1999; Owner of
Record: Centre National de la Recherche Scientifique (C.N.R.S.); Title:
Nor Bis-indole Compounds Usable as Medicaments; Classification: 514/214;
Product Trade Name: NAVELBINE R; Term Extended: 1,053 days.

U.S. Patent No. 4,739,101; Granted: April 19, 1988, to Jean-Pierre
Bourgogne et al.; Original Expiration Date: April 27, 2007; Owner of
Record: Fournier Innovation et Synergie; Title: METHOD FOR THE
PREPARATION OF FIBRATES; Classification: 560/61; Product Trade Name:
Lipidil R; Term Extended: 248 days.

U.S. Patent No. 4,753,935; Granted: June 28, 1988, to Peter H. Nelson et
al.; Original Expiration Date: January 30, 2007; Owner of Record: Syntex
(U.S.A.) Inc.; Title: Morpholinoethylesters of Mycophenolic Acid and
Pharmaceutical Compositions Classification: 514/233; Product Trade Name:
CELLCEPT R; Term Extended: 824 days.

U.S. Patent No. 4,804,680; Granted: February 14, 1989, to Alexander C.
Goudie et al.; Original Expiration Date: July 21, 2007; Owner of Record:
Pfizer Inc.; Title: POLYCYCLIC ETHER ANTIBIOTIC; Classification:
414/460; Product Trade Name: AVIAX R; Term Extended: 237 days.

U.S. Patent No. 4,844,882; Granted: July 4, 1989, to Kenneth J. Widder;
Original Expiration Date: December 29, 2007; Owner of Record: Molecular
Biosystems, Inc.; Title: Concentrated Stabilized Microbubble-type
Ultrasonic Imaging Agent; Classification: 424/9.52; Product Trade Name:
ALBUNEX R; Term Extended: 220 days.

U.S. Patent No. 4,957,924; Granted: September 18, 1990, to Lilia M.
Beauchamp; Original Expiration Date: August 4, 2008; Owner of Record:
Burroughs Wellcome Co.; Title: Therapeutic Valine Esters of Acyclovir
and Pharmaceutically Acceptable Salts Thereof; Classification: 514/262;
Product Trade Name: VALTREX  R; Term Extended: 323 days.